[Anti-progestins and contraception].
Fuentealba
B
B
Instituto Chileno de Medicina Reproductiva, Santiago, Chile.
Salvatierra
A M
AM
Croxatto
H B
HB
D003276:Contraceptives, Oral / Q000494:pharmacology; D003282:Contraceptives, Postcoital, Hormonal / Q000494:pharmacology; D010064:Embryo Implantation / Q000187:drug effects; D004717:Endometrium / Q000187:drug effects; D004963:Estrenes / Q000494:pharmacology; D005260:Female; D005938:Glucocorticoids / Q000037:antagonists & inhibitors; D006067:Gonanes / Q000494:pharmacology; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D015735:Mifepristone / Q000494:pharmacology; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011372:Progestins / Q000037:antagonists & inhibitors*; D011980:Receptors, Progesterone / Q000037:antagonists & inhibitors*
D003276:Contraceptives, Oral; D003282:Contraceptives, Postcoital, Hormonal; D004963:Estrenes; D005938:Glucocorticoids; D006067:Gonanes; D011372:Progestins; D011980:Receptors, Progesterone; D015735:Mifepristone; C048260:lilopristone; D007986:Luteinizing Hormone; C053238:onapristone
Antiprogestinas en anticoncepción.